Article
Use of AXL-specific CAR T cells to treat non-small-cell lung cancer
2021-02-16
Abstract excerpt
<title>Abstract</title> <p>The application of Chimeric antigen receptor (CAR) T cells in solid tumors is hindered by lack of tumor specific targets and inefficient T cell infiltration in tumor. It has been postulated that AXL may be an ideal immunotherapy target for non-small-cell lung cancer (NSCLC). Here, we screened 208 non-tumor samples from 22 types of human organs or tissues and 90 tumor samples from NSCLC...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 649685d2-6a0f-5918-9808-2b83eba79d2a
- DOI
- 10.21203/rs.3.rs-244810/v1
